7Baggers
 Cardiff Oncology to Participate in Two Upcoming Investor Conferences  GlobeNewswire Thu, 02 Oct 2025 20:07:22 GMT
 cardiff oncology shares face sustained selling pressure  AD HOC NEWS Fri, 26 Sep 2025 13:18:05 GMT
 published on: 2025-09-20 03:24:39  خودرو بانک Fri, 19 Sep 2025 23:58:27 GMT
 published on: 2025-09-19 18:29:16  khodrobank.com Fri, 19 Sep 2025 15:03:13 GMT
 published on: 2025-09-17 13:59:11  خودرو بانک Wed, 17 Sep 2025 10:33:27 GMT
 published on: 2025-09-17 13:59:11  khodrobank.com Tue, 16 Sep 2025 20:03:38 GMT
 published on: 2025-09-16 04:00:25  خودرو بانک Tue, 16 Sep 2025 00:32:07 GMT
 published on: 2025-09-15 12:44:30  خودرو بانک Mon, 15 Sep 2025 09:18:31 GMT
 Cardiff Oncology at H.C. Wainwright: Onvansertib’s Promising Path  Investing.com Tue, 09 Sep 2025 07:00:00 GMT
 published on: 2025-09-04 00:32:22  Newser Thu, 04 Sep 2025 05:32:22 GMT
 published on: 2025-09-03 14:37:09  khodrobank.com Wed, 03 Sep 2025 07:00:00 GMT
 published on: 2025-09-02 00:18:09  Newser Tue, 02 Sep 2025 05:18:09 GMT
 published on: 2025-09-02 00:47:06  beatles.ru Mon, 01 Sep 2025 20:47:06 GMT
 published on: 2025-08-31 23:29:47  Newser Mon, 01 Sep 2025 04:29:47 GMT
 published on: 2025-08-30 11:40:38  Newser Sat, 30 Aug 2025 16:40:38 GMT
 published on: 2025-08-29 21:23:41  Newser Sat, 30 Aug 2025 02:23:41 GMT
 published on: 2025-08-29 12:55:47  Newser Fri, 29 Aug 2025 17:55:47 GMT
 Cardiff Oncology to Participate in Three Upcoming Investor Conferences  The Manila Times Fri, 29 Aug 2025 07:00:00 GMT
 published on: 2025-08-28 13:10:04  Newser Thu, 28 Aug 2025 18:10:04 GMT
 published on: 2025-08-28 05:24:56  Newser Thu, 28 Aug 2025 10:24:56 GMT
 Cardiff Oncology to Participate in Three Upcoming Investor Conferences  GlobeNewswire Thu, 28 Aug 2025 07:00:00 GMT
 published on: 2025-08-28 00:54:22  Newser Thu, 28 Aug 2025 05:54:22 GMT
 cardiff oncology stock soars 12.22% on clinical trial success  AInvest Tue, 26 Aug 2025 07:00:00 GMT

Cardiff Oncology, Inc
(NASDAQ:CRDF) 

CRDF stock logo

Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops drugs for the treatment of cancer. Its lead drug candidate is onvansertib, a Polo-like Kinase 1 selective adenosine triphosphate competitive inhibitor that is in Phase Ib/II clinical trial in acute myeloid leukemia (AML); has c...

Founded: 1999
Full Time Employees: 12
CEO: Mark Erlander  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends